Efficacy and safety of the intensive dose of rosuvastatin 40 mg/day in patients with acute coronary syndrome and at high risk of cardiovascular disease-ROSUVEES-2()

BACKGROUND: Randomized clinical trials have established the benefits of statin therapy in acute coronary syndromes (ACS) via their pleiotropic effects. AIM OF THE STUDY: This was a 12-week, open-label, multicenter, postmarketing observational study evaluating the efficacy and safety of rosuvastatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Chetan P., Shah, Bhaskar P., Dani, Sameer I., Channa, B.B., Lakshmanan, S.S., Krishnamani, N.C., Mehta, Ashwani, Moorthy, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143813/
https://www.ncbi.nlm.nih.gov/pubmed/27931543
http://dx.doi.org/10.1016/j.ihj.2016.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143813/
https://www.ncbi.nlm.nih.gov/pubmed/27931543
http://dx.doi.org/10.1016/j.ihj.2016.09.002

Ejemplares similares